Effectiveness of Placental Drainage in the Third Stage of Labor: a Randomized Clinical Trial
NCT ID: NCT01655576
Last Updated: 2013-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
226 participants
INTERVENTIONAL
2012-08-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Placental Drainage of Management of the Third Stage of Labor:a Randomized Controlled Study
NCT01931423
Placental Cord Drainage Versus no Placental Drainage in the Management of Third Stage of Labour
NCT03137810
Intraumbilical Oxytocin Versus Placental Cord Drainage in the Management of 3rd Stage of Labor
NCT03395730
Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)
NCT05560802
Prevention of Post-partum Haemorrhage
NCT01044082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Routine clamping
After delivery of the newborn, umbilical cord at mothers end, will be left clamped until delivery of the placenta.
No interventions assigned to this group
Placental drainage
After delivery of the newborn, umbilical cord at mothers end, will be left unclamped until delivery of the placenta.
Placental drainage
After delivery of the newborn, umbilical cord at mothers end, will be left unclamped until delivery of the placenta.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placental drainage
After delivery of the newborn, umbilical cord at mothers end, will be left unclamped until delivery of the placenta.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnancy at term
* Women at low risk for assisted labor / delivery and postpartum care.
* Live Fetus
Exclusion Criteria
* Women who agreed to participate signed the Informed Consent, but evolved to cesarean section or instrumental delivery by forceps;
* Instrumental Delivery by forceps or c-section
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Materno Infantil Prof. Fernando Figueira
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leila Katz
MD pHD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IMIP
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vasconcelos FB, Katz L, Coutinho I, Lins VL, de Amorim MM. Placental cord drainage in the third stage of labor: Randomized clinical trial. PLoS One. 2018 May 2;13(5):e0195650. doi: 10.1371/journal.pone.0195650. eCollection 2018.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pla1
Identifier Type: REGISTRY
Identifier Source: secondary_id
PLADRAINAGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.